Alzheimer's disease and diabetes mellitus
https://doi.org/10.21518/2079-701X-2015-18-36-40
Abstract
Recently, healthcare specialists have put great emphasis on the relationship between Alzheimer's disease and diabetes. There are many common pathogenic mechanisms underlying both diseases: insulin resistance, hyperinsulinemia, chronic hyperglycemia, acute hypoglycemic episodes, microangiopathy, inflammation, dyslipidemia, etc. It is assumed that there is a direct link between insulin and Alzheimer's disease. Insulin regulates β-amyloid synthesis as well as tau phosphorylation. Cognitive impairment and dementia associated with diabetes can also be mediated through vascular factors including, primarily, development of microangiopathy. Еру vascular and neurodegenerative components can be mutually intensified. One of the key elements in the pathogenesis of cognitive degradation is impaired cholinergic transmission. Acetylcholinesterase inhibitors are the drugs of choice for the treatment of both Alzheimer's disease and vascular dementia. The effectiveness of donepezil (Alzepil) has been proved in numerous trials: it is characterized by the best tolerability compared with other cholinergic drugs and is the only drug in the group recommended for use in severe stages of Alzheimer's disease.
About the Author
A. N. Bogolepova
Russian Medical Research University named after N.I. Pirogov
Russian Federation
Russian Federation
References
1. Информационный бюллетень ВОЗ №362, 2015 Март http://www.who.int/mediacentre/ factshe ets/fs362/ru/.
2. Mayeux R. Apolipoprotein E, Alzheimer disease, and African Americans. Arch Neurol. 2003. 60(2): 161-3.
3. http://циабет.рф/about-dia betes/risk-factors/ diabetes-in-figures.
4. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999. 53(9): 1937-1942.
5. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004. 63(4): 658-663.
6. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One. 2009. 4(1): 4144.
7. Biessels GJ, Staekenborg S, Brunner E et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurology. 2006. 5(1): 64-74.
8. Akomolafe A, Beiser A, Meigs JB et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol. 2006. 63(11): 1551-5.
9. Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-anal-ysis of prospective observational Studies. Journal of Diabetes Investigation. 2013. 4, 6: 640-650.
10. Irie F, Fitzpatrick AL, Lopez OL, et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol. 2008. 65(1): 89-93.
11. Ascher-Svanum H, Chen Y-F, Hake A, Kahle-Wrobleski K, Schuster D, Kendall D, Heine RJ. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or With out Comorbid Diabetes. Clin Ther. 2015. 37: 1195-1205.
12. Winkler A, Dlugaj M, Weimar C, Jockel K-H, Erbel R, Dragano N, et al. Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women. J Alzheimers Dis. 2014. 42: 1269-77.
13. Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014. 161: 785-93.
14. Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, Okonkwo OC, La Rue A, Hermann BP, Koscik RL, Jonaitis EM, Sager MA, Asthana S Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. JAMA Neurol. 2015 Jul 27. doi: 10.1001/jama-neurol.2015.0613. [Epub ahead of print]).
15. Feinkohl I, Price JF, Strachan MWJ, Frier bM. The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimer's Research & Therapy. 2015. 7: 46-67.
16. Williamson JD, Launer LJ, Bryan RN, Coker LH, Lazar RM, Gerstein HC, et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med. 2014. 174: 324-33.
17. Enzinger Ch, Smith S, Fazekas F et al. Lesion probability maps of white matter hyperintensi-ties in elderly individuals results of the Austrian stroke prevention study. J Neurol. 2006. 253: 1064-1070.
18. Чугунова Л.А., Семенова И.В., Орлов Ю.Ю., Шеста-кова М.В. Сахарный диабет 2 типа и когнитивные нарушения. Сахарный диабет, 2008. 1: 61-66.
19. Bruce DG, Davis WA, Casey GP, Clarnette RM, Brown SG, Jacobs IG, et al. Severe hypoglycae-mia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia. 2009. 52: 1808-15.
Review
For citations:
Bogolepova AN. Alzheimer's disease and diabetes mellitus. Meditsinskiy sovet = Medical Council. 2015;(18):36-40. (In Russ.) https://doi.org/10.21518/2079-701X-2015-18-36-40
Views:
1745
Email this article 